An observational study in Digestive or Non-digestive Neoplasia Leading to Symptomatic Duodenal Stenosis, sponsored by Institut Paoli-Calmettes. Recruiting at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2018-03-13.
Sponsored by Institut Paoli-Calmettes · Observational
To assess the efficacy of duodenal prostheses for duodenal stenosis established for endoscopic pyloric or duodenal stenosis on dysphagia
Duodenal prostheses have become, since the 2000s, the first-line treatment of unresectable duodenal tumoral stenosis. The technical success is greater than 90%, however the endoscopic revisions that are duodenal or biliary are frequent. The IPC as a center of interventional endoscopy is very often in charge of these stenoses. We wanted to evaluate the efficiency and the duration of this effectiveness in current situation. Is there still room for gastrojejunal gastrojejunal surgery or for the development of endoscopic gastrojejunal anastomoses?
9 studies on the registry are indexed under Pyloric Stenosis; 1 is open to participants now.
Browse Pyloric Stenosis studies →Institut Paoli-Calmettes is the lead sponsor of 172 studies on the registry; 50 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Any symptomatic duodenal stenosis with symptomatic duodenal duodenal prosthesis between 2010 and 2017.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Any symptomatic duodenal stenosis with symptomatic duodenal duodenal prosthesis between 2010 and 2017.
Device: uncovered metal duodenal prosthesis
Implantation of an uncovered metal duodenal prosthesis for symptomatic tumor stenosis
Dysphagia assessment
GOOSS = Gastric Outlet Obstruction Scoring System
Time frame: 7 years
Rate of complications
Rate of complications
Time frame: 7 years
postoperative survival
defined as the time between the date of duodenal prosthesis insertion and the date of death or the latest news
Time frame: 7 years
Permeability duration of the duodenal stent
defined as the time between the date of the laying of the duodenal stent and date of patient's death or RED or surgery (exceptional case) or latest news
Time frame: 7 years
Rate of duodenal endoscopic resection at 1 and 3 months postoperatively
Rate of duodenal endoscopic resection at 1 and 3 months postoperatively
Time frame: at 1 and 3 months postoperatively
Rate of biliary endoscopic resection at 1 and 3 months postoperatively
Rate of biliary endoscopic resection at 1 and 3 months postoperatively
Time frame: at 1 and 3 months postoperatively
Plan to share: No
Started Dec 2017 (actual). Primary completion is estimated for Dec 2029, 144 months after the start.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.